PD-L1 levels of expression on cancer cells can be determined immunohistochemically and is reported as the tumor proportion score TPS, on immune cells, reported as IC, and calculated for both sides as the combined positivity score (CPS). This evidence concerns the gene CD274 and neoplasm.